Uncategorized

Big4Bio Announces Partnership With The Bullpen on Preparing for JPM Week 2023

Along with Big4Bio’s On Your Mark guide, this weekly series will help attendees plan for the week of the J.P. Morgan Healthcare Conference in San Francisco SAN FRANCISCO — (BUSINESS WIRE) — Big4Bio, the leading aggregator of life science news and developments in the top biohubs in the country, announces it is partnering with Christiaan […]

Read More

2 Cardiovascular Biotech Companies You Should Know About

We all know that heart disease is the leading cause of death in the United States. What you might not know is that there are a number of innovative Cardiovascular Biotech Companies working on developing new treatments and cures for cardiovascular disease. Here are two of them. Take a look at these companies CVRx Inc […]

Read More

Is Biotechnology Laboratory Analytical Instruments a Good Career Path

When people think about biotechnology, they often picture scientists in a lab creating drugs or any medical product. But, the reality is that biotechnology is more than lab work. With the latest modern discoveries, there are new challenges to be solved. Biotechnology provides a wide range of opportunities for several different professionals. For them to […]

Read More

The Big4Bio Company to Watch Program
September 2022: Life Science Cares

Life Science Cares leverages the power of the life science industry to solve one of our most intractable social issues—poverty. They currently operate in locations that boast a critical mass of companies working in biotech, pharmaceuticals, medical technology, and research: Boston, Philadelphia, San Diego and the San Francisco Bay Area — the Big4Bio regions. Life […]

Read More

Why Pursue a Career in Biotechnology Engineering

In the last decades, there are some careers that have been on-demand, like the case of biotechnology engineering. Since events like the COVID-19 pandemic, experts in medical health are looking for biotechnology engineers. These professionals can help battle this public health problem. Humanity as a society has faced several problems during history. Today, we are […]

Read More

Advancing a New Class of Medicines

Company to Watch – NeuBase Therapeutics In the second of four features on NeuBase Therapeutics, Big4Bio spoke with Founder and CEO Dietrich Stephan and CFO Todd Branning about the company’s precision genetic medicine technology and pipeline, partnering and financing activities, and plans moving forward. By Marie Daghlian Todd Branning, chief financial officer of NeuBase Therapeutics, […]

Read More

Drugging the Genome

Company to Watch – NeuBase Therapeutics In the first of four features on NeuBase Therapeutics, Big4Bio spoke with Founder and CEO Dietrich Stephan and CFO Todd Branning about the spark behind founding of the company, and how it is drugging the genome with precision genetic medicine. The second feature will provide an in-depth focus on […]

Read More

Modelling Biology: A Q&A with Cellarity’s CSO

Company to Watch – Cellarity In the final article in the Company to Watch series on Cellarity, Big4Bio editor Marie Daghlian spoke with Chief Scientific Officer Laurens Kruidenier about what impressed him about the company, what he sees as the strength of the Cellarity platform and how it works, and why we should keep our […]

Read More

A Platform to Uncover Biological Complexity to Target Virtually Any Disease

Company to Watch – Cellarity In the second of four features on Cellarity, Big4Bio spoke with CEO Fabrice Chouraqui about the company’s unique platform, initial pipeline, and plans moving forward. by Marie Daghlian Cellarity aims to discover medicines that can resolve human disease, potentially any disease. To do this it has developed a cell-centric platform […]

Read More

RESI’s First Digital Conference Successful

by Marie Daghlian The global COVID-19 pandemic has changed life as we know it, severely curtailing local and global travel, and postponing or cancelling many conferences and meetings around the world. For the RESI conference organizer Life Science Nation (LSN), however, it has presented an opportunity to go digital, and in fact, after they made […]

Read More

Big3Bio’s Rebranding Brings Big Changes

With the addition of the Greater Philadelphia Area, Big4Bio rounds out its coverage of biopharmaceutical updates from the biggest bioclusters in the world. Here at Big3Bio, the scheduled launch of our brand-new Philadelphia newsletter has kept everyone on their toes. But this June, the much spoken of transformation for Big3Bio will finally come to pass. […]

Read More

Big3Bio and BIO Publish “On Your Mark 2019: The Complete Guide to JPM Week”

BIO CEO Jim Greenwood, Laurie Halloran, CEO of Halloran Consulting, and Tilton Little, Executive Director of Big3Bio, provide the Introduction and Welcomes to this year’s guide SAN FRANCISCO, CA–(December 17, 2018)–Big3Bio, the leading aggregator service for the top biotech hubs in the US—Boston, San Francisco Bay Area, and San Diego—proudly announces the debut of “On […]

Read More

Big3Bio Publishes BIOWeek:Boston 2018, The Complete Guide to the Week of #BIO2018

SAN FRANCISCO, CA–(May 25, 2018)–Big3Bio, the leading aggregator service for the top biotech hubs in the US—Boston, San Francisco Bay Area, and San Diego—proudly announces the first version of BIOWeek:Boston 2018, the compendium of everything going on during the week of the BIO International Convention (#BIO2018), June 3-8. BIOWeek:Boston 2018 not only lists/links all of the major conferences occurring […]

Read More